In humans, circadian-like patterns of GLP-1 levels, as well as a reduction in the amplitude of GLP-1 release in individuals with obesity and type 2 diabetes have been observed. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.